Correlation Between Sonnet Biotherapeutics and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Cardio Diagnostics.
Diversification Opportunities for Sonnet Biotherapeutics and Cardio Diagnostics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sonnet and Cardio is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Cardio Diagnostics
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Cardio Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 2.48 times less risky than Cardio Diagnostics. The stock trades about -0.58 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Cardio Diagnostics Holdings on August 28, 2024 and sell it today you would lose (4.00) from holding Cardio Diagnostics Holdings or give up 12.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Cardio Diagnostics |
Sonnet Biotherapeutics and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Cardio Diagnostics
The main advantage of trading using opposite Sonnet Biotherapeutics and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |